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Study participants were older female twins (mean age = 58 years old; age range: 1 0 8
19-82 years old; 83% are MZ and 10% are DZ) who were enlisted in the 1 0 9
TwinsUK registry [14] . The TwinsUK registry is one of the largest adult twin 1 1 0 cohorts encompassing a wide range of phenotypes, and biological samples and was obtained from 528 female individuals (mean age 57.9), and tooth mobility 1 1 5
data was obtained from 492 female individuals (mean age 58.0), for whom blood 1 1 6
DNA methylation profiles were also available. The date of the clinical visit for 1 1 7 periodontal data collection was within 5 years of the blood DNA extraction date. We integrated our genome-wide differential methylation profiles in periodontal 3 1 7 disease with previously published candidate regions for chronic periodontitis. Altogether, we explored data at 28 regions (256 CpG-sites) that were previously 3 1 9
identified either through GWAS efforts or biological studies into periodontal 3 2 0 disease ( Table 2) . We observed evidence for enrichment of epigenetic 3 2 1 associations with both periodontal traits in the blood epigenome-wide results 3 2 2 ( Figure 3A) . In blood, 26 CpG sites (tooth mobility) and 15 CpG sites (gingival 3 2 3 bleeding) were nominally significantly associated with dental phenotypes. CpG 3 2 4 sites that were nominally significantly associated with both periodontal traits 3 2 5 mapped to eight genes (VDR, IL6ST, TMCO6, IL1RN, CD44, IL1B, WHAMM, 3 2 6 and CXCL1). To assess the persistence of dental phenotype associations across tissues, we 3 2 8 carried out additional epigenetic analyses between both periodontal traits and 3 2 9
two further epigenetic datasets from buccal and adipose tissue. In buccal tissue, 3 3 0 a stronger phenotype enrichment was observed compared to that in blood 3 3 1 ( Figure 3B ), and 51 (tooth mobility) and 38 (gingival bleeding) CpG sites were 3 3 2 nominally associated with the dental phenotypes. CpG sites that were genes detected in blood. In summary, moderate to strong enrichment of dental tissue ( Figure 3C ).
4 0
We further explored the eight genes at which nominally significant differential 2.42e-6 (7.83e-7); p-value = 2.2e-3, exon 3 4 9
ENSG00000156232.5_83495140_83495248: beta (SE) = 2.68e-6 (9.13e-7); 3 5 0 p-value = 3.6e-3, exon ENSG00000156232.5_83477973_83479087: beta (SE) 3 5 1 = 2.73e-6 (9.36e-7); p-value = 3.9e-3) and TMCO6 (exon 3 5 2 ENSG00000113119.8_140023365_140023551: beta (SE) = -0.37 (0.13);
3 5 3 p-value = 6.0e-3). Second, to further explore their functional contribution, we 3 5 4
examined the association between the methylation levels of the 3 5 5
phenotype-associated CpG-sites in these two genes (cg00115297 in WHAMM 3 5 6 and cg00916199 in TMCO6) and fasting blood metabolites profiles. Nominally 3 5 7 significant associations with methylation levels at these CpGs were observed for metabolites. Six out of 23 identified metabolites in a nominally significant We present the first large-scale epigenome-wide study of periodontitis. Our 3 6 7 results identified differential methylation at specific CpG sites between 3 6 8 periodontal trait positive and negative individuals, which suggests that 3 6 9
epigenetic changes may help explain the variation in the susceptibility to chronic 3 7 0 periodontitis. Our findings detected hypo-methylation in the 5'UTR of ZNF804A metabolites, including ornithine and carnitine, which were significantly 3 7 6 2 5 associated with the differential methylation signal in ZNF804A. Ornithine was 3 7 7
reported to play an important role on metabolic cross-feeding between 3 7 8
Streptococcus gordonii and Fusobacterium nucleatum [25] . S. godonii is 3 7 9
considered to express an arginine-ornithine antiporter, which potentially could
influence the inter-bacterial communication with periodontal pathogens. Kuboniwa's group also reported that the level of ornithine in saliva showed a elevate the level of ornithine in blood. In terms of more severe stages of periodontal disease, where tooth mobility or 3 8 9
self-reported history of gum disease is a more appropriate phenotype marker, 3 9 0
we identified 58 CpG sites with epigenome-wide significant signals, although the observed genomic inflation may result in an increase in the number of false 3 9 2 positive findings that we report here [27] . The most strongly associated signal for 3 9 3 this phenotype was in the gene body of the IQCE gene and was 3 9 4
hyper-methylated in individuals who presented with tooth mobility, the severe 3 9 5 stage of periodontitis. However, there was not a significant signal for 3 9 6 differential gene expression in this gene. Gene expression patterns associated 3 9 7
with methylation levels at tooth-mobility associated signals were obtained at 3 3 9 8
CpG sites (out of 58 CpG-sites) and in three genes (MAD1L1, TRAPPC9, and reports that DNA methylation levels can be under genetic control [28] . The most striking finding of our results was generated from a candidate gene Our study has a number of limitations. Firstly, we used self-reported data to power of the study to detect a true difference between groups, but makes a type Another limitation of our periodontal information is the time difference between 4 5 8
DNA extraction time and dental phenotype collection, and dental questionnaires 4 5 9
which capture the history of periodontal conditions rather than current status.
However, we excluded participants for whom the time difference between DNA 4 6 1 extraction and dental questionnaires was over 5 years. We reasoned that inflammation.
6 5
Another limitation is our ability to address tissue specificity in disease relevant Epigenome-wide association scans (EWAS), Genome-wide association scans permitted to be shared or deposited due to the original consent given at the time of data collection. However, access to these metabolite and phenotype data can be applied for through the TwinsUK data access committee. For information on 5 2 0 access and how to apply 5 2 1 http://www.twinsuk.ac.uk/data-access/submission-procedure/.
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Figure 2. Epigenome-wide association results on tooth mobility. (A)
Epigenome-wide association results, where green dotted line shows the epigenome-wides significant threshold (8.00e-06). There are 58 points epigenome-wide significant association with tooth mobility, showing positive (red) and negative (blue) correlation with tooth mobility. (B) The percentage of each genetic, shared environmental and unique environmental factor contribution to the variance in methylation levels at the 58 CpG-sites. Pink (A, heritability), green (C, common environment), and blue (E, unique environment) bars represent genetic, shared environmental and unique environmental effects respectively. Three CpGs denoted by * are located in or near to genes that also showed exon expression levels with a nominally significant association with tooth mobility.
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